Here are relevant reports on : human-resource-technology-market
-
Dark Analytics Market by Component (Solutions, Services), Deployment Mode (Cloud, On-premises), Business Application (Marketing, Operations, Finance, Human Resources), Vertical (BFSI, Healthcare), and Region - Global Forecast to 2023
The dark analytics market is expected to grow from USD 278.3 million in 2018 to USD 867.7 million by 2023, at a CAGR of 25.5% from 2018 to 2023. The dark analytics market is projected to witness significant growth during the forecast period, majorly driven by the rapid increase in data generated by organizations, the adoption of artificial intelligence, and machine learning technologies for dark data analysis, and increase in the deployment of dark analytics solutions. Increasing investments in dark analytics technology by SMEs is one of the opportunities for growth in the dark analytics market. Dark analytics helps organizations in managing campaigns, making quick decisions, analyzing markets, and deriving customer insights. Dark analytics empowers the decision-making process of SMEs and enable them to easily identify existing and future business risks. The major vendors covered in the dark analytics market include IBM (US), SAP (Germany), Amazon Web Services (US), Micro Focus (UK), Dell EMC (US), Microsoft (US), AvePoint (US), Teradata (US), Symantec (US), Datameer (US), IRI (US), SAS (US), Commvault (US), Veritas (US), Cohesity (US), Datumize (Spain), SynerScope (Netherlands), Komprise (US), Lattice (US), Quantta Analytics (India), Zoomdata (US), Formcept (India), Globanet (US), Esdebe Consultancy (UK), and Levi, Ray & Shoup (US).
- Published: July 2018
- Price: $ 4950
- TOC Available:
-
Probiotic Ingredients Market by Application (Functional Foods & Beverages, Pharmaceuticals, and Animal Nutrition), Source (Bacteria and Yeast), Form (Dry and Liquid), End User (Human and Animal), and Region - Global Forecast to 2023
The probiotic ingredients market is projected to grow from USD 268 million in 2018 to USD 402 million by 2023, at a compound annual growth rate (CAGR) of 8.5% during the forecast period. The increasing demand for dietary supplements in the pharmaceuticals, cosmetics, and personal care industries is projected to drive the market for probiotics, which in turn, is projected to drive the market growth for probiotic ingredients.
- Published: December 2018
- Price: $ 4950
- TOC Available:
-
Electrical SCADA Market by Architecture (Hardware, Software, and Services), Component (Master Terminal unit, Remote Terminal unit, Human Machine Interface), Application (Generation, Transmission, and Distribution), and Region - Global Forecast to 2022
The electrical SCADA market is expected to grow from an estimated USD 2.29 Billion in 2017 to USD 3.29 Billion by 2022, at a CAGR of 7.48%, during the forecast period. This growth can be attributed to factors such as increased investments in electrical networks and government initiatives toward the adoption of industrial automation. To enable an in-depth understanding of the competitive landscape, the report includes the profiles of some of the top players in the electrical SCADA market. These players include ABB (Switzerland), Schneider (France), Rockwell Automation (US), Yokogawa (Japan), Honeywell (US), Siemens (Germany), Larsen & Toubro (India), Mitsubishi (Japan), Emerson (US), Open system International (US), Advanced Control System (US), and Bentek Systems (Canada). These players adopted various strategies such as new product launches, contracts & agreements, and investments and expansions, to increase their global presence and market share.
- Published: January 2018
- Price: $ 4950
- TOC Available:
-
Human Microbiome Manufacturing Services Market by Type (Fermentation & Downstream Processing, Strain Development & Optimization), Disease (Infectious, Gastrointestinal, Endocrine & Metabolic Disease) - Global Forecast to 2031
The global Human Microbiome Manufacturing Services market, valued at US$0.09 billion in 2024, stood at US$0.11 billion in 2025 and is projected to advance at a resilient CAGR of 16.7% from 2025 to 2031, culminating in a forecasted valuation of US$0.27 billion by the end of the period. Growing demand for specialized capabilities, such as anaerobic fermentation, microbial process scale-up, formulation, and fill-finish, is fueling broader adoption of human microbiome manufacturing services.
- Published: September 2026
- Price: $ 4950
- TOC Available:
-
Human Microbiome Drugs Market by Type (Live Biotherapeutic Products, Fecal Microbiota-derived Therapeutics), Disease (Gastrointestinal, Infectious), End User (Hospitals, Clinics, Long-term Care) - Global Forecast to 2031
The human microbiome drugs market, valued at US$0.09 billion in 2024, stood at US$0.35 billion in 2025 and is projected to advance at a resilient CAGR of 35.2% from 2025 to 2031, culminating in a forecasted valuation of US$2.13 billion by the end of the period. The human microbiome drugs market is growing, driven by the increasing clinical success of live biotherapeutic products, rising prevalence of chronic and recurrent diseases, and expanding therapeutic applications beyond gastrointestinal disorders into metabolic, immune, and neurological conditions.
- Published: September 2026
- Price: $ 4950
- TOC Available:
-
Antibody Therapeutics Market by Product (Commercial, Pipeline), Format (mAb, ADC, Fragment), Target (PDL1, Cytokine), Therapy area (Oncology, Neurology, Inflammatory), Source (Human, Humanized), ROA (IV, SC), Region, Competition - Global Forecast to 2035
The global antibody therapeutics market is projected to reach USD 597.1 billion by 2035, growing at a CAGR of 7.5% during the forecast period (2026–2035). The report covers key segments, regional analysis, and competitive landscape across the market ecosystem.
- Published: July 2026
- Price: $ 4950
- TOC Available:
-
Single Cell Analysis Market by Product (Consumables (Beads, Kits, Reagents), Instruments), Cell Type (Human, Animal), Technique (Flow Cytometry, NGS, PCR, Microscopy), Application (Research (Cancer, Neurology), Medical (NIPT, IVF)) - Global Forecast to 2030)
The global single-cell analysis market, valued at US$3.55 billion in 2024, stood at US$3.81 billion in 2025 and is projected to advance at a resilient CAGR of 14.7% from 2025 to 2030, culminating in a forecasted valuation of US$7.56 billion by the end of the period.Growth in this market can be attributed to factors such as the rising incidence of cancer and immunological disorders, technological developments in single-cell analysis products, the growing focus on the advancement of stem cell research, and the increasing focus on the biotechnology sector.
- Published: May 2025
- Price: $ 4950
- TOC Available:
-
Artificial Cornea and Corneal Implant Market by Type (Human Cornea, Artificial Cornea), Transplant Type (Penetrating Keratoplasty, Endothelial Keratoplasty), Disease Indication, End Users (Hospitals, Specialty Clinics & ASCs) - Global Forecast to 2026
The global artificial cornea and corneal implant market in terms of revenue was estimated to be worth $418 million in 2021 and is poised to reach $599 million by 2026, growing at a CAGR of 7.4% from 2021 to 2026. Some of the major players operating in the market are AJL Ophthalmic (Spain), CorneaGen Inc. (US), Addition Technology, Inc. (US), LinkoCare Life Sciences AB (Sweden), Presbia plc (Ireland), Mediphacos (Brazil), Aurolab (India), Cornea Biosciences (US), DIOPTEX GmbH (Austria), EyeYon Medical (Israel), Massachusetts Eye and Ear (US), Florida Lions Eye Bank (US), SightLife (US), Advancing Sight Network (US), San Diego Eye Bank (US) and L V Prasad Eye Institute (LVPEI, India).
- Published: February 2021
- Price: $ 4950
- TOC Available:
-
Human Centric Lighting Market by Offering (Hardware (Lighting fixtures and Lighting Controllers), Software, and Services), Installation Type (New Installations and Retrofit Installations), Application, and Geography - Global Forecast to 2036
The human centric lighting market was valued at USD 3.66 billion in 2024 and is projected to reach USD 25.25 billion by 2036, growing at a CAGR of 17.1% from 2025 to 2036 The growth of the human centric lighting market is driven by the high adoption of LED lighting solutions; initiatives toward establishing smart cities; and the rising in demand for energy-efficient lighting solutions. The implementation of wireless technology for LED lighting is expected to provide huge growth opportunities to market players. The human centric lighting market is currently dominated by Signify Lighting NV (Netherlands), OSRAM Licht AG (Germany), Acuity Brands, Inc. (US), Cree, Inc. (US), Legrand SA (France), Hubbell Inc. (US), Zumtobel Group AG (Austria), Wipro Enterprises (P) Ltd. (India), Glamox AS (Norway), and Lutron Electronics Co., Inc. (US). A few of the major strategies adopted by these players to compete in the human centric lighting market include product launches and developments, partnerships, and mergers and acquisitions.
- Published: October 2026
- Price: $ 4950
- TOC Available:
-
Human Organoids Market by Product (Liver, Kidney, Pancreatic Models (2D, 3D)), Disease Area (Oncology, GI, Neurological Disorders), Application (Drug Toxicity, Personalized Medicine), End User (Pharma & Biotech Companies, CROs) - Global Forecast to 2029
The global human organoids market, valued at US$1.07 billion in 2023, stood at US$1.19 billion in 2024 and is projected to advance at a resilient CAGR of 14.4% from 2024 to 2029, culminating in a forecasted valuation of US$2.33 billion by the end of the period. The main factor driving this market is the rising demand for organoids in drug testing, as they provide more reliable results than conventional 2D cell cultures.
- Published: December 2024
- Price: $ 4950
- TOC Available:
Records 41 to 50 of 50
